Industry Reports
Bristol-Myers Squibb reports first quarter 2013 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported financial results for the first quarter of 2013, and confirmed GAAP EPS and non-GAAP EPS guidance ranges for...
Industry Reports
Abbott reports first-quarter 2013 results
Abbott announced financial results for the first quarter ended March 31, 2013. Worldwide sales of nearly $5.4 billion increased 3.5 percent on an operational...
Industry Reports
Bristol-Myers Squibb to Announce Results for First Quarter 2013...
Bristol-Myers Squibb Company will announce results for the first quarter of 2013 on Thursday April 25 2013. During a conference call at 10:30 a.m....
Industry Reports
A strong cash position of EUR 30.5 million, an...
Adocia, a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today its financial results for 2012. ...
Industry Reports
Adocia reports 2012 revenue multiplied by 2.5 with a...
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already approved therapeutic proteins, announces today its revenue for the full...
Industry Reports
Sanofi delivers solid 2012 results despite patent expirations
In the fourth quarter of 2012, Sanofi generated sales of €8,526 million, an increase of 0.2% on a reported basis. Exchange rate movements had...
Industry Reports
Roche delivers strong 2012 results
Roche delivered a strong performance in 2012, with Group sales rising 4% to 45.5 billion Swiss francs due to growing demand for its cancer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.